F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval by BY REBECCA ROBBINS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.

Published: July 9, 2021 at 07:48PM

from NYT Health https://ift.tt/3qZb1Uo